eurotimes.org
EUROTIMES STORIES

PRESBYOPIA CORRECTING IOL

Colin Kerr

Posted: Thursday, April 1, 2021

AcuFocus has submitted a Premarket Approval (PMA) application to the Food and Drug Administration (FDA)for its IC-8 small aperture IOL.

“The IC-8 IOL is a first-of-its-kind presbyopia-correcting lens that is designed to deliver seamless visual acuity from near to far without the ‘blurry zones’ found in traditional lens designs,” said Magda Michna, PhD, Chief Global Clinical, Medical & Regulatory Affairs Officer, AcuFocus.

“We are incredibly grateful to our investigators, their teams and the patients who participated in the study.”

www.acufocus.com


Latest Articles


escrs members advert